T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Usana Health Sciences
USNA
$252M
| $307K | ﹤0.01% |
11,138
+678
| +6% | +$20.9K |
|
2577
Forum Energy Technologies
FET
$927M
| $306K | ﹤0.01% |
11,442
+103
| +0.9% | +$2.38K |
|
2578
Mid Penn Bancorp
MPB
$971M
| $306K | ﹤0.01% |
10,660
+105
| +1% | +$3.06K |
|
2579
Equity Bancshares
EQBK
$1.07B
| $304K | ﹤0.01% |
7,445
-241
| -3% | -$9.76K |
|
|
AHL
2580
DELISTED
Aspen Insurance
AHL
| $304K | ﹤0.01% |
8,261
-241,739
| -97% | -$7.95M |
|
2581
Graham Corp
GHM
$1.3B
| $303K | ﹤0.01% |
5,507
+327
| +6% | +$16.7K |
|
2582
United States Antimony
UAMY
$799M
| $303K | ﹤0.01% |
48,734
+2,770
| +6% | +$11.6K |
|
2583
McEwen Inc
MUX
$1.14B
| $302K | ﹤0.01% |
17,615
| – | – |
|
2584
PetMed Express
PETS
$43.4M
| $302K | ﹤0.01% |
120,055
| – | – |
|
2585
RxSight
RXST
$292M
| $302K | ﹤0.01% |
33,528
+10,426
| +45% | +$91.5K |
|
2586
Heritage Insurance Holdings
HRTG
$989M
| $301K | ﹤0.01% |
11,928
+1,211
| +11% | +$27.5K |
|
2587
Editas Medicine
EDIT
$432M
| $300K | ﹤0.01% |
86,220
+33,083
| +62% | +$92.3K |
|
2588
ImmunityBio
IBRX
$8.11B
| $298K | ﹤0.01% |
121,054
+6,057
| +5% | +$15.6K |
|
2589
RE/MAX Holdings
RMAX
$265M
| $297K | ﹤0.01% |
31,475
+309
| +1% | +$2.73K |
|
2590
National Bankshares
NKSH
$272M
| $296K | ﹤0.01% |
10,027
+498
| +5% | +$14.7K |
|
|
TRUE
2591
DELISTED
TrueCar
TRUE
| $296K | ﹤0.01% |
160,683
-85,548
| -35% | -$172K |
|
2592
Ardagh Metal Packaging
AMBP
$3.16B
| $295K | ﹤0.01% |
73,816
+4,029
| +6% | +$16K |
|
|
SNBR
2593
DELISTED
Sleep Number
SNBR
| $295K | ﹤0.01% |
42,003
+7,196
| +21% | +$63K |
|
2594
Eton Pharmaceutcials
ETON
$1.12B
| $294K | ﹤0.01% |
13,524
+684
| +5% | +$11.4K |
|
|
LAND
2595
Gladstone Land Corp
LAND
$358M
| $294K | ﹤0.01% |
32,089
-9,936
| -24% | -$93.9K |
|
|
STKL
2596
DELISTED
SunOpta
STKL
| $294K | ﹤0.01% |
50,126
+5,018
| +11% | +$31.1K |
|
2597
Digimarc Corp
DMRC
$158M
| $293K | ﹤0.01% |
29,969
+5,683
| +23% | +$61.3K |
|
2598
PubMatic
PUBM
$787M
| $293K | ﹤0.01% |
35,312
+1,229
| +4% | +$12.5K |
|
2599
iShares Russell 3000 ETF
IWV
$20.6B
| $290K | ﹤0.01% |
764
| – | – |
|
2600
Arhaus
ARHS
$1.37B
| $289K | ﹤0.01% |
27,106
+3,363
| +14% | +$35.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.